Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial-Reference-Cited by-同舟云学术

Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial

Published:2015-04 Issue:4 Volume:16 Page:417-425
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Petrylak Daniel P,Vogelzang Nicholas J,Budnik Nikolay,Wiechno Pawel Jan,Sternberg Cora N,Doner Kevin,Bellmunt Joaquim,Burke John M,de Olza Maria Ochoa,Choudhury Ananya,Gschwend Juergen E,Kopyltsov Evgeny,Flechon Aude,Van As Nicolas,Houede Nadine,Barton Debora,Fandi Abderrahim,Jungnelius Ulf,Li Shaoyi,de Wit Ronald,Fizazi Karim

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. Androgen receptor signaling in androgen-refractory prostate cancer;Grossmann;J Natl Cancer Inst,2001

3. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study;Berthold;J Clin Oncol,2008

5. Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer;Trump;Prostate,2011

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer;The Prostate;2024-03-27

2. Targeted Therapies: Novel Treatment Strategies for Prostate Cancer;Transforming Prostate Cancer Care;2024

3. Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer;Medical Decision Making;2023-10

4. Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs;International Journal of Molecular Sciences;2023-09-03

5. Conditional survival does not improve over time in metastatic castration‐resistant prostate cancer patients undergoing docetaxel;The Prostate;2023-06-08